Inspire Investing LLC Has $4.31 Million Stock Position in Encompass Health Corporation $EHC

Posted by George Bondi on Jun 18th, 2026

Inspire Investing LLC raised its stake in Encompass Health Corporation (NYSE:EHC – Free Report) by 82.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 40,647 shares of the company’s stock after buying an additional 18,399 shares during the period. Inspire Investing LLC’s holdings in Encompass Health were worth $4,314,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. boosted its position in Encompass Health by 3,059,159.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after buying an additional 3,793,358 shares in the last quarter. AlphaCore Capital LLC acquired a new stake in Encompass Health in the fourth quarter valued at approximately $4,881,000. JPMorgan Chase & Co. boosted its position in Encompass Health by 5.3% in the third quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock valued at $179,141,000 after buying an additional 70,387 shares in the last quarter. Tudor Investment Corp ET AL boosted its position in Encompass Health by 155.3% in the third quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company’s stock valued at $26,765,000 after buying an additional 128,191 shares in the last quarter. Finally, SG Americas Securities LLC boosted its position in Encompass Health by 1,070.9% in the fourth quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock valued at $9,346,000 after buying an additional 80,534 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on EHC shares. Barclays cut their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. TD Cowen initiated coverage on shares of Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price on the stock. Weiss Ratings reiterated a “buy (b-)” rating on shares of Encompass Health in a report on Monday, June 8th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Leerink Partners set a $152.00 price target on shares of Encompass Health in a report on Friday, May 22nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $143.86.

Check Out Our Latest Stock Analysis on EHC

Encompass Health Price Performance

Shares of NYSE:EHC opened at $98.04 on Thursday. The firm has a market cap of $9.73 billion, a PE ratio of 16.37, a price-to-earnings-growth ratio of 2.18 and a beta of 0.72. The firm’s fifty day moving average is $104.26 and its 200-day moving average is $104.23. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99.

Encompass Health (NYSE:EHC – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. The company had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. Encompass Health’s revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Sell-side analysts predict that Encompass Health Corporation will post 5.97 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 annualized dividend and a yield of 0.8%. Encompass Health’s payout ratio is presently 12.69%.

Insider Transactions at Encompass Health

In related news, EVP Patrick William Tuer sold 682 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares in the company, valued at $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.80% of the stock is currently owned by insiders.

About Encompass Health

(Free Report)

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.